BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2026.
World J Gastroenterol. Feb 7, 2026; 32(5): 113024
Published online Feb 7, 2026. doi: 10.3748/wjg.v32.i5.113024
Figure 9
Figure 9 Benzoylpaeoniflorin protected against dextran sulfate sodium-induced injury through activating β-catenin in vitro. A: Molecular docking of benzoylpaeoniflorin and β-catenin protein and their binding sites; B and C: Western blotting analysis of protein expression of Claudin1; D-F: Western blotting analysis of protein expression of β-catenin and Cyclin D1; G-I: Western blotting analysis of protein expression of Claudin1 and leucine-rich repeat-containing G-protein coupled receptor 5. For all the experiments: n = 4. aP < 0.05 vs dextran sulfate sodium group, cP < 0.001 vs dextran sulfate sodium group. ns: No significance compared with dextran sulfate sodium + ICG-001 group; DSS: Dextran sulfate sodium; Lgr5: Leucine-rich repeat-containing G-protein coupled receptor 5; Ben: Benzoylpaeoniflorin.


Write to the Help Desk